<DOC>
	<DOCNO>NCT01255020</DOCNO>
	<brief_summary>The prospective , double blind randomize , parallel control , multi-center clinical trial evaluate safety efficacy α-keto acid restrict protein diet protect residual renal function continuous ambulatory peritoneal dialysis ( CAPD ) patient .</brief_summary>
	<brief_title>Renal Protective Effects Restricted Protein Dietary With α-keto Acid CAPD Patients</brief_title>
	<detailed_description>Residual renal function ( RRF ) associate cardiovascular complication , nutritional status , incidence peritonitis , quality life peritoneal dialysis ( PD ) patient . Therefore , RRF important determinant mortality morbidity PD patient . Previous study suggest dietary protein restriction supplement α-keto acid may slow loss RRF chronic kidney disease patient . However , trial small sample short-time research . In PD patient , report indicate effect α-keto acid restrict protein diet RRF . The aim study evaluate safety efficacy α-keto acid restrict protein diet protect residual renal function continuous ambulatory peritoneal dialysis ( CAPD ) patients.This prospective , double blind randomize , parallel control , multi-center clinical study . 160 patient meet Inclusion/Exclusion criterion randomize α-Keto Acid group control group ratio 1:1 . The α-Keto Acid group use compound α-Keto Acid plus restrict protein diet , control group use placebo plus restricted protein diet.The α-Keto Acid dosage 100mg/kg/d daily . The restricted protein dosage 1g/kg/d . The safety efficacy α-Keto Acid restrict protein diet RRF evaluate 1 year treatment .</detailed_description>
	<mesh_term>Renal Insufficiency</mesh_term>
	<criteria>1 . Patients peritoneal dialysis ( PD ) least three month prior study entry . 2 . Subjects either sex , 18 year old , range age 18 70 year old . 3 . Residual GFR ≥ 3 ml/min/1.73m2 . 4 . Without αKeto Acid therapy recent 4 week . 5 . Subjects agree participate study sign inform consent . 1 . History peritonitis infection within one month . 2 . Patients insufficient dialysis . 3 . History take drug may influence amino acid metabolism within one month ( glucocorticoid , thyroxin , antithyroid drug , androgen , amino acid , et al ) . 4 . Patients diseases contraindicate ketosteril . 5 . Can control diet accord protocol . 6 . Alcohol abuse drug abuse . 7 . Having malignant tumor . 8 . History psychiatric neuropathic dysfunction . 9 . Cardiac failure , New York Heart Association ( NYHA ) grade IIIIV history severe heart cerebrovascular disease recent one month ( acute stroke , acute heart failure , Lability angina ) 10 . Serum albumin &lt; 30g/l . 11 . Serum calcium &gt; 2.8mmol/l . 12 . Participation another clinic trial within last three month</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>α-Keto Acid</keyword>
	<keyword>Restricted Protein Diet</keyword>
	<keyword>Residual Renal Function</keyword>
</DOC>